Brian Richards, who heads up part of the Motley Fool's international operations, and I were in Toronto last week. We stopped by Morningstar Canada to talk shop and meet the group's editorial team.
We asked about the differences between Canadian and American investors, and the talk quickly moved to something I wasn't aware of: How much more Canadian mutual fund investors pay in fees compared with their American neighbors.
"The typical American mutual fund charges, I don't know, maybe 1%," I noted. "What's a typical Canadian pay?"
"Double that, easily," Morningstar's managing editor Christian Charest told me.
That's no exaggeration. A few years ago, Morningstar put together a detailed side-by-side analysis of investment funds around the world. While Canada gets high marks overall, it's in a league of its own when it comes to fees. Here's Morningstar:
The typical investor in a Canadian equity fund pays a [management expense ratio] of between 2.00% and 2.50%.
Hot Building Product Stocks To Own Right Now: Valeant Pharmaceuticals International Inc(VRX)
Valeant Pharmaceuticals International, Inc., a specialty pharmaceutical company, develops, manufactures, and markets pharmaceutical products in the areas of neurology, dermatology, and branded generics. It offers Wellbutrin XL to treat depressive disorders; Xenazine to treat chorea associated with Huntington?s disease; CeraVe to rebuild and repair skin barrier; and Kinerase, a cosmetic product. The company also provides Zovirax ointment to treat initial genital herpes; Xerese to treat recurrent herpes labialis; Elidel to treat atopic dermatitis; and Acanya and Atralin gels to treat acne vulgaris. In addition, it offers Cesamet to treat nausea and vomiting associated with cancer chemotherapy; Tiazac XC to treat hypertension and angina; Wellbutrin to treat depressive illness; Sublinox to treat insomnia; and Lodalis to treat hypercholesterolemia. Further, the company provides Cold-FX to strengthen immune system; Duromine/Metermine for weight loss; Difflam to treat sore throa ts; and Duro-Tuss and Rikodeine to treat dry and chesty cough, as well as various branded generics for treatments, including antibiotics, treatments for cardiovascular and neurological diseases, antifungal medications, and diabetic therapies. Additionally, it offers Bisocard to treat hypertension and angina pectoris; Flucinar, a corticosteroid ointment; and Sachol mouth ulcer gel; Bedoyecta to treat neurotic pain; M.V.I., a hospital dietary supplement for trauma and burns; Tandene to treat fever and headache; Melleril to treat anxiety and depression; and products for therapeutic classes, such as vitamin deficiency, antibacterials, and dermatology. It markets its products in the United States, Canada, Australia, New Zealand, Europe, Latin America, southeast Asia, and South Africa. The company was formerly known as Biovail Corporation and changed its name to Valeant Pharmaceuticals International, Inc. in September 2010. The company was founded in 1960 and is headquartered in M ississauga, Canada.
Advisors' Opinion:- [By Eric Lam]
Canadian stocks rose, erasing earlier losses of as much as 0.3 percent to clinch a fifth week of gains, as a surge in Valeant Pharmaceuticals International Inc. (VRX) offset a slump in oil and gold producers.
- [By Sean Williams]
Another factor that can't be overlooked is that Endo hasn't been shy about putting the for-sale sign out in the front yard. In late January, Warner Chilcott�and Valeant Pharmaceuticals (NYSE: VRX ) were both rumored to be interested in acquiring Endo. Things have certainly changed since then, with Actavis�(formerly Watson Pharmaceuticals) purchasing Warner Chilcott and Valeant currently arranging financing to purchase privately held eye products maker Bausch & Lomb for $8.7 billion. That shouldn't, however, discourage other suitors looking for hybrid growth in both branded and generic drugs from making a play for the very profitable Endo.
- [By Jake L'Ecuyer]
Allergan (NYSE: AGN) shares were also up, gaining 15.49 percent to $163.99 on buyout offer from Valeant Pharmaceuticals International (NYSE: VRX).
- [By Brendan Mathews]
We asked which current CEOs fit the�Outsiders�mold. Thorndike reeled off a short list of names, but he started with Michael Pearson of�Valeant Pharmaceuticals� (NYSE: VRX ) . He went on to mention Nicholas Howley of�TransDigm Group� (NYSE: TDG ) , and Rich Kinder of�Kinder Morgan� (NYSE: KMI ) .�
5 Best Canadian Stocks To Invest In Right Now: Primerica Inc.(PRI)
Primerica, Inc., together with its subsidiaries, engages in the distribution of financial products on behalf of third parties to middle income households in the United States and Canada. The company operates in three segments: Term Life Insurance, Investment and Savings Products, and Corporate and Other Distributed Products. The Term Life Insurance segment underwrites term life insurance products. The Investment and Savings Products segment distributes mutual funds, variable annuities, fixed annuities, and segregated funds. The Corporate and Other Distributed Products segment provides mortgage loans, which include debt consolidation or refinance, and purchase money loans; unsecured loans; prepaid legal services that assist subscribers with legal matters, such as drafting wills, living wills and powers of attorney, trial defense, and motor vehicle-related matters; mail-order student life products; short-term disability benefit insurance; and auto and homeowners? insurance products. The company was founded in 1927 and is based in Duluth, Georgia.
Advisors' Opinion:- [By Rich Duprey]
Private equity investor Warburg Pincus has been a shareholder in term life insurance underwriter Primerica� (NYSE: PRI ) since its IPO in 2010. However, the financial products marketer will be buying back all of the holdings Warburg Pincus owns for $154.7 million. That translates into�almost�2.5 million shares of common stock�and warrants that �are�exercisable for 4.1 million shares.
5 Best Canadian Stocks To Invest In Right Now: China Metro-Rural Holdings Limited(CNR)
China Metro-Rural Holdings Limited, through its subsidiaries, primarily engages in the development and operation of agricultural logistics and trade centers in northeast China. It also involves in purchasing, processing, assembling, merchandising, and distributing pearls and jewelry products. The company markets its pearls and jewelry products to wholesale distributors and mass merchandisers in Europe, the United States, Hong Kong, and other parts of Asia. In addition, it develops, sells, and leases residential and commercial properties in Hong Kong and the People?s Republic of China. The company is based in Tsimshatsui, Hong Kong.
Advisors' Opinion:- [By Katie Brennan]
Canadian National Railway Co. (CNR) added 0.9 percent to C$104.93 and Canadian Pacific Railway Ltd. rose 1.7 percent to C$131.73.
Niko Resources surged 3.4 percent to $8.64 after the company entered an agreement for a $60 million loan that will be funded by a group of institutional investors. Net proceeds from the loan will be used to fund working capital requirements.
5 Best Canadian Stocks To Invest In Right Now: El Paso Electric Company (EE)
El Paso Electric Company, a public utility company, engages in the generation, transmission, and distribution of electricity primarily in west Texas and southern New Mexico. It principally operates nuclear, natural gas, and coal power plants, as well as wind turbines. As of December 31, 2010, the company owned 6 electrical generating facilities with a net generating capacity of approximately 1,643 megawatts. It serves approximately 370,000 residential, commercial, industrial, public authority, and wholesale customers. The company sells its products to electric utilities and power marketers, as well as to oil and copper refining, and steel production facilities, universities, and the United States military installations. El Paso Electric Company was founded in 1901 and is based in El Paso, Texas.
Advisors' Opinion:- [By Tyler Crowe]
If we were to pinpoint a company that�embodies�this�success�as of late, it's First Solar (NASDAQ: FSLR ) . It just sold a 139 megawatt facility to�utility�giant -- and large coal consumer -- Southern (NYSE: SO ) , and recently signed a power purchase deal with El Paso Electric (NYSE: EE ) that will supply El Paso with electricity for half what it pays for power from coal. These deals also come with the announcement that the company upped guidance earlier in April which sent share prices up by 46% in one day.�
- [By Tyler Crowe]
It may have been a long time coming, but the technology for renewable fuels is very close to the point that they can can compete on the open market against traditional energy sources. First Solar just recently announced a deal with El Paso Electric (NYSE: EE ) that it will sell electricity to El Paso from its Macho Springs solar facility for 5.79 cents per kilowatt hour, less than half what El Paso pays for electricity from coal. Also, the Federal Energy Regulation Commission has stated that 83% of all additional energy generation in the U.S. for Q1 2013 came from either wind or solar facilities. Perhaps the route to developing better solutions wasn't the smoothest, but it's hard to deny the overall outcome.�
No comments:
Post a Comment